Gèrard Socié

Research interests

Publications

• Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

  New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2109965

• Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

  Bone Marrow Transplantation · 2020 · https://doi.org/10.1038/s41409-020-0803-y

• Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation

  The Lancet Haematology · 2020 · https://doi.org/10.1016/s2352-3026(19)30256-x

• Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1917635

• Current issues in chronic graft-versus-host disease

  Blood · 2014 · 10.1182/blood-2014-01-514752

• Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

  JAMA · 2014 · https://doi.org/10.1001/jama.2014.6368

• Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

  Transplantation and Cellular Therapy · 2014 · https://doi.org/10.1016/j.bbmt.2014.10.021

• Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria

  British Journal of Haematology · 2013 · 10.1111/bjh.12347

• Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

  Bone Marrow Transplantation · 2013 · https://doi.org/10.1038/bmt.2013.107

• Bone Marrow Failure in Fanconi Anemia Is Triggered by an Exacerbated p53/p21 DNA Damage Response that Impairs Hematopoietic Stem and Progenitor Cells

  Cell stem cell · 2012 · https://doi.org/10.1016/j.stem.2012.05.013

• The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

  Nature Reviews Clinical Oncology · 2012 · https://doi.org/10.1038/nrclinonc.2012.150

• Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

  Blood · 2011 · https://doi.org/10.1182/blood-2011-08-375840

• Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation

  Journal of Clinical Oncology · 2011 · 10.1200/jco.2010.33.7212

• Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

  Blood · 2011 · https://doi.org/10.1182/blood-2011-01-329821

• Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

  Nature · 2010 · 10.1038/nature09328

• Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

  The Lancet Oncology · 2009 · https://doi.org/10.1016/s1470-2045(09)70225-6

• Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

  Blood · 2009 · 10.1182/blood-2008-09-178046

• Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

  Blood · 2008 · https://doi.org/10.1182/blood-2008-01-133918

• Solid cancers after allogeneic hematopoietic cell transplantation

  Blood · 2008 · 10.1182/blood-2008-05-158782

• Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group

  Haematologica · 2007 · https://doi.org/10.3324/haematol.10699

• Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation

  Haematologica · 2007 · https://doi.org/10.3324/haematol.10075

• Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease

  Blood · 2007 · https://doi.org/10.1182/blood-2007-03-079665

• Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria

  Blood · 2007 · 10.1182/blood-2007-06-095646

• The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

  New England Journal of Medicine · 2006 · 10.1056/nejmoa061648

• Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

  Bone Marrow Transplantation · 2006 · https://doi.org/10.1038/sj.bmt.1705265

• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

  Transplantation and Cellular Therapy · 2005 · 10.1016/j.bbmt.2005.09.004

• Nonmalignant late effects after allogeneic stem cell transplantation

  Blood · 2003 · 10.1182/blood-2002-07-2231

• Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey

  The Lancet · 2001 · 10.1016/s0140-6736(01)05482-4

• Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.

  PubMed · 1999

• Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

  New England Journal of Medicine · 1999 · https://doi.org/10.1056/nejm199907013410103

• IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE

  British Journal of Haematology · 1997 · https://doi.org/10.1046/j.1365-2141.1997.1112925.x

• Solid Cancers after Bone Marrow Transplantation

  New England Journal of Medicine · 1997 · https://doi.org/10.1056/nejm199703273361301

• Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors

  The Lancet · 1996 · 10.1016/s0140-6736(95)12360-1

• Malignant Tumors Occurring after Treatment of Aplastic Anemia

  New England Journal of Medicine · 1993 · 10.1056/nejm199310143291603

Current projects

No projects listed.